April 2022 Newsletter

Addressing the unique regulatory challenges of gene therapies

  Go Back

Start a conversation today

Socials:









    By submitting this form, you understand that Cencora may process your data as described in the Cencora Privacy Policy

    We are now Cencora PharmaLex 

    PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

    Know more